Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Vandana Singh

UnitedHealth Q1 Earnings Beat Consensus Helped By Growth Across Segments

UnitedHealth Group Inc (NYSE:UNHreported Q1 FY22 sales of $80.1 billion, up 14.2% Y/Y, beating the consensus of $78.76 billion, with double-digit growth at both Optum and UnitedHealthcare.

  • Adjusted EPS of $5.49 surpassed the consensus of $5.37 and was better than $5.31 a year ago.
  • The company generated an operating cash flow of $5.3 billion or 1.0x net income.
  • The medical care ratio was 82% compared to 80.9% a year ago due to COVID effects and business mix.
  • The operating cost ratio of 14.2% decreased from 14.6% in Q1 FY21 due to COVID effects and continued productivity advances, partially offset by business mix and investments.
  • Related: UnitedHealth Scoops Up Home-Health Firm LHC Group In $5.4B Deal.
  • UnitedHealthcare segment Q4 revenues grew 13.6% to $62.6 billion compared to last year, with operating earnings of $3.8 billion compared to $4.1 billion last year.
  • Optum segment sales were up 18.9% to $43.3 billion, and operating earnings rose to $3.2 billion from $2.6 billion a year ago.
  • Guidance: UnitedHealth expects FY22 adjusted EPS of $21.20 - $21.70, up from prior outlook of $21.10 - $21.60. 
  • Price Action: UNH shares closed 0.21% lower at $536.80 during after-hours trading on Wednesday.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.